HDAC9 and cancer: All in all, we can assume that the integration of HDAC and ROCK inhibitory functions in a single molecule could potentially increase the efficacy of anticancer drugs by simultaneously targeting multiple signaling pathways involved in cancer cell proliferation, survival, and metastasis, thus representing a new and effective strategy for cancer therapy.